NeueHealth (NYSE:NEUE) Shares Down 0.1% - Here's What Happened

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) traded down 0.1% during trading on Wednesday . The stock traded as low as $7.30 and last traded at $7.34. 10,659 shares were traded during trading, a decline of 72% from the average session volume of 37,964 shares. The stock had previously closed at $7.35.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada cut their target price on NeueHealth from $8.00 to $7.00 and set a "sector perform" rating on the stock in a research report on Monday, December 9th.

NeueHealth Price Performance

The company has a market cap of $60.78 million, a PE ratio of -0.14 and a beta of 0.57. The business's fifty day simple moving average is $6.22 and its two-hundred day simple moving average is $5.62.

NeueHealth (NYSE:NEUE - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($6.78) earnings per share for the quarter, missing analysts' consensus estimates of ($2.72) by ($4.06). The company had revenue of $232.93 million during the quarter, compared to analysts' expectations of $230.21 million. NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. During the same period in the prior year, the business posted ($8.31) earnings per share. As a group, analysts predict that NeueHealth, Inc. will post -9.13 EPS for the current year.

Insider Transactions at NeueHealth

In other NeueHealth news, CEO George Lawrence Mikan III sold 16,803 shares of NeueHealth stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54. Following the completion of the sale, the chief executive officer now directly owns 83,029 shares in the company, valued at $347,061.22. This trade represents a 16.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jay Matushak sold 4,970 shares of the company's stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the transaction, the chief financial officer now owns 17,747 shares in the company, valued at approximately $130,085.51. This represents a 21.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 58,658 shares of company stock valued at $377,034. Corporate insiders own 64.30% of the company's stock.

Institutional Trading of NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. Partners Group Holding AG bought a new stake in shares of NeueHealth, Inc. (NYSE:NEUE - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 88,645 shares of the company's stock, valued at approximately $463,000. Partners Group Holding AG owned approximately 1.07% of NeueHealth at the end of the most recent quarter. 63.88% of the stock is owned by hedge funds and other institutional investors.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.